Psychodynamic Therapy Returns for Conversion Disorder

October 6, 2026by Chris Aiken, MD0

Sigmund Freud started his career as a neurologist. He first used his therapy couch (above) to treat the unexplained neurologic symptoms of conversion disorder.

12 sessions of psychodynamic therapy worked, but the study has flaws

STUDY: Dal Pasquale BG et al, Clin Neurol Neurosurg 2026

STUDY TYPE: Randomized controlled trial (pilot)

FUNDING: Brazilian federal research agency (CAPES)

Background

Psychotherapy is first line for conversion disorder, including seizures and neurological symptoms without a known origin. However, the largest CBT trial (CODES) failed to reduce seizures. Psychodynamic therapy, which explores conflicts and trauma behind symptoms, has mostly been tested in uncontrolled studies.

The Study
  • 91 adults at a Brazilian public clinic with conversion disorder (two-thirds with seizures, one-third with motor symptoms). Most had trauma histories, and few believed their symptoms were psychological in origin.
  • Randomized to 12 weekly sessions of short-term psychodynamic therapy plus standard care, or standard care alone; 74 completed 6-month follow-up.
Results

The primary outcome, days of symptoms, fell from 18 to 9 per month with therapy versus 17 to 15 with standard care (effect size 0.77). Two-thirds of the therapy group improved by at least 50%, versus 17% of controls (NNT 2). However, full remission was rare (16% vs 6%, not significant).

Therapy also improved depression (HAM-D, effect size 1.45), anxiety (HAM-A, 1.06), and disability (WHODAS 2.0, 0.74).

The improvements held steady at 6 months and were similar across subtypes.

Side Effects

None.

Limitations

A single-site pilot with two therapists, unblinded. Therapists rated each other’s patients, controls got no comparable attention, and registration was retrospective.

Practice Implications
  1. Psychodynamic therapy is feasible, and works better than treatment as usual. We’ll await comparisons with active treatments.

—Chris Aiken, MD
Director, Psych Partners
Editor in Chief, Carlat Psychiatry Report

What’s Your Take? Share in Comments

Leave a Reply

Your email address will not be published. Required fields are marked *